2014至2021年日本75岁以上类风湿关节炎患者疾病活动度趋势:ANSWER队列研究
基于日本多中心观察性注册数据库,分析2014至2021年32161次患者就诊记录,发现75岁以上类风湿关节炎患者比例从16.5%升至26.9%,其缓解和低疾病活动度达标比例从62.2%显著升至78.2%(趋势P<0.001)。糖皮质激素使用、血清阳性和既往生物制剂/靶向合成DMARDs使用与达标负相关,甲氨蝶呤使用正相关。
要点
- 75岁以上类风湿关节炎患者缓解和低疾病活动度比例从62.2%升至78.2%(趋势P<0.001)。
- 糖皮质激素使用、血清阳性及既往b/tsDMARDs使用与缓解和低疾病活动度负相关。
- 甲氨蝶呤使用与缓解和低疾病活动度正相关,独立于其他预测因素。
核心结论
- 在该队列中,75岁以上类风湿关节炎患者的疾病活动度随时间改善,研究提示对高龄患者采用达标治疗策略对改善临床结局具有重要性。
研究设计与样本
- 日本类风湿关节炎患者观察性多中心注册研究,分析2014至2021年共32161次患者就诊记录。
主要发现
- 75岁以上患者比例从16.5%升至26.9%,生物制剂和靶向合成DMARDs使用增加、糖皮质激素使用减少,传统合成DMARDs使用相对稳定。
- 75岁以上类风湿关节炎患者达到缓解和低疾病活动度的比例从62.2%升至78.2%(趋势P<0.001)。
- 糖皮质激素使用、血清阳性和既往b/tsDMARDs使用是与达到缓解和低疾病活动度负相关的因素,甲氨蝶呤使用正相关,独立于其他预测因素。
临床怎么用
- 研究提示对75岁以上类风湿关节炎患者采用达标治疗策略对改善临床结局具有重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate if disease activity among elderly RA patients >75 years of age has changed over time in the real-world clinical setting. METHODS: Data from an observational multicentre registry of RA patients in Japan were analysed. The primary outcome was to evaluate the changes in the proportion of very elderly RA patients (>75 years) who achieved remission and low disease activity (LDA), from 2014 to 2021. The secondary outcome was to identify factors associated with remission and LDA by comparing demographic and clinical characteristics among the patients who had a study visit within the study period, using multivariate logistic regression. RESULTS: A total of 32 161 patient visits were identified from 2014 to 2021. The proportion of patients >75 years of age increased from 16.5% to 26.9%, with biologics and targeted synthetic DMARDs (b/tsDMARDs) use increasing and glucocorticoids use decreasing, while conventional synthetic DMARDs use remained relatively stable. The proportion of RA patients >75 years of age achieving remission and LDA significantly increased from 62.2% to 78.2% (P for trend < 0.001). A negative factor associated with achieving remission and LDA was glucocorticoid use, seropositivity and a history of previous b/tsDMARDs use while MTX use was associated positively, independent of other predictors. CONCLUSIONS: In our cohort, disease activity among very elderly RA patients has improved over time. The study suggests the importance of using a treat-to-target approach in very elderly RA patients to improve clinical outcomes.
引用
- Yamada H, Jinno S, Maeda T, et al. Trends of disease activity in Japanese patients over 75 years with rheumatoid arthritis from 2014 to 2021: the ANSWER cohort study. Rheumatology (Oxford). 2024. PMID: 37792494. doi:10.1093/rheumatology/kead539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。